Non-ST-segment Elevation Myocardial Infarction
5
0
0
2
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 39/100
20.0%
1 terminated out of 5 trials
66.7%
-19.8% vs benchmark
60%
3 trials in Phase 3/4
50%
1 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Study on High-sensitivity Troponin 0h/1h for Rapid Diagnosis of Non-ST-segment Elevation Myocardial Infarction in the Chinese Population
Influence of Morphine on Pharmacokinetics and Pharmacodynamics of Ticagrelor in Patients With Acute Myocardial Infarction
Optimised Procedure in Patients With NSTEMI and CKD
OCT Based Edge and In-stent Vascular Response After Cordimax Stent in patIents With NSTE-ACS
Comparison of the Angiographic Result of the Orsiro Hybrid Stent With Resolute Integrity Stent